JW
James N Wilson (Director) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Corcept Therapeutics Incorporated (CORT). The largest single filing was $1.1M of CORT (10,000 sh across 3 lots, as filed), executed Aug 14. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$3.8M
shares × price, as filed
Last traded
Oct 15
Filed Oct 16
Median ADV $130.9M across their filed names
Open performance→Volume by month
Buys $0
Sells $3.8M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Sector per market data · by filing · past 12 months
Most traded names
CORTRecent filings
CORTSALE
Corcept Therapeutics Incorporated
View filing →
$1.1M9,700 sh across 2 lots
Exec Oct 15
Filed Oct 16 · 6:24 PM ET CORTSALE Corcept Therapeutics Incorporated View filing → $1.1M
10,000 sh across 3 lots
Exec Aug 14
Filed Aug 18 · 4:30 PM ET CORTSALE Corcept Therapeutics Incorporated View filing → $789K
8,921 sh across 3 lots
Exec Jul 15
Filed Jul 17 · 6:38 PM ET CORTSALE Corcept Therapeutics Incorporated View filing → $832K
10,000 sh across 2 lots
Exec Jun 16
Filed Jun 18 · 5:30 PM ET